A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugsElena Crisà, Dario Ferrero, Ermanno Venturino et al.|Annals of Hematology|2010Cited by 60
Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based studyAytug Kizilors, Hugues de Lavallade, Elena Crisà et al.|The Lancet Haematology|2019Cited by 56
Diagnostic capabilities, clinical features, and longitudinal <scp><i>UBA1</i></scp> clonal dynamics of a nationwide <scp>VEXAS</scp> cohortCarmelo Gurnari, Maria Teresa Voso, Paola Triggianese et al.|American Journal of Hematology|2023Cited by 43
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agentsDario Ferrero, Mario Boccadoro, Elena Crisà et al.|Annals of Hematology|2014Cited by 31
Methodology and clinical utility of longitudinal <scp><i>UBA1</i></scp> tracking in <scp>VEXAS</scp> syndromeCarmelo Gurnari, Maria Teresa Voso, Elisa Galossi et al.|British Journal of Haematology|2024Cited by 10